Growth & profitability
- Revenue has grown 6.1% per year over the past 5 years.
SRTS Financials Sensus Healthcare, Inc.
11 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $27M | -$8M | 43.2% | -37.5% | $332000 | — | $22M |
| 2024 | $42M | $7M | 58.4% | 19.4% | -$1M | — | $22M |
| 2023 | $24M | $485000 | 57.6% | -1.6% | -$2M | — | $23M |
| 2022 | — | $24M | — | — | -$2M | — | $26M |
| 2021 | — | $4M | — | — | -$414000 | — | $15M |
| 2020 | — | -$7M | — | — | -$793000 | — | $15M |
| 2019 | — | -$2M | — | — | -$3M | — | $8M |
| 2018 | — | -$2M | — | — | — | — | $12M |
| 2017 | — | -$4M | — | — | — | — | $10M |
| 2016 | — | -$346448 | — | — | — | — | $5M |
| 2015 | — | -$237267 | — | — | — | — | $5M |
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key quarterly figures
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $3M | -$3M | 29.2% | -128.4% | -$4M | — | $18M |
| Dec '25 | $5M | -$3M | 38.4% | -63.7% | -$2M | — | $22M |
| Sep '25 | $7M | -$943000 | 39.4% | -37.3% | $2M | — | $24M |
| Jun '25 | $7M | -$1M | 39.7% | -26.6% | $3M | — | $22M |
| Mar '25 | $8M | -$3M | 52.2% | -31.7% | -$3M | — | $19M |
| Dec '24 | $13M | $2M | 54.4% | 13.2% | -$530000 | — | $22M |
| Sep '24 | $9M | $1M | 59.3% | 16.9% | $4M | — | $23M |
| Jun '24 | $9M | $2M | 58.7% | 21.5% | $4M | — | $19M |
| Mar '24 | $11M | $2M | 62.5% | 27.1% | -$8M | — | $15M |
| Dec '23 | $13M | $4M | 62.3% | 44.4% | $3M | — | $23M |
| Sep '23 | $4M | -$1M | 51.0% | -48.6% | $431000 | — | $20M |
| Jun '23 | $5M | -$380000 | 57.9% | -24.9% | $713000 | — | $20M |
| Mar '23 | $3M | -$2M | 47.5% | -86.1% | -$6M | — | $19M |
| Dec '22 | $13M | $3M | 63.7% | 31.8% | -$10M | — | $26M |
| Sep '22 | $9M | $2M | 65.2% | 24.0% | $4M | — | $38M |
| Jun '22 | $12M | $4M | 68.3% | 37.8% | $2M | — | $34M |
| Mar '22 | $10M | $16M | 69.2% | 38.0% | $3M | — | $33M |
| Dec '21 | $13M | $5M | 68.0% | 40.8% | -$2M | — | $15M |
| Sep '21 | $6M | $195000 | 57.9% | 3.5% | $1M | — | $16M |
| Jun '21 | $5M | -$279000 | 61.7% | -5.1% | $1M | — | $15M |
Valuation over time
How the market has priced SRTS against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-earnings ratio has risen from 3.5× (Mar '23) to 10.2× (Nov '25).
- The price-to-sales ratio has fallen from 2.2× (Jan '24) to 1.8× (Jun '26).
P/E
P/S
Frequently asked questions
Is SRTS growing its revenue and profit?
Over the past 5 years, Sensus Healthcare, Inc.'s revenue has grown 6.1% per year. These are computed facts, not advice.
How much debt does SRTS have?
As of FY2025, Sensus Healthcare, Inc. reported — of total debt against $22M of cash.
What is SRTS's profit margin?
In FY2025, gross margin was 43.2%, operating margin -37.5%, and net margin -28.1%.
What is SRTS's P/E ratio?
As of Jun '26, Sensus Healthcare, Inc. traded at a price-to-earnings ratio of about 10.2× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.